Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
Watchlist
Compare
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
Metrics
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Fiscal Year
FY TTM
FY NaN
FY NaN
FY NaN
FY NaN
NaN - NaN
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '11
Dec 31, 2011
Dec '10
Dec 31, 2010
Dec '09
Dec 31, 2009
NaN - NaN
Licensing Fees
997.73K
Log In
Log In
Log In
Log In
Upgrade
Licensing Fees Growth
-42.66%
Log In
Log In
Log In
Log In
Upgrade
Peptide and Consumer Product
-
Log In
Log In
Log In
Log In
Upgrade
License Fee and Peptide Sales
-
Log In
Log In
Log In
Log In
Upgrade
License Fee and Peptide Sales Growth
-
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Fiscal Year
FY TTM
FY NaN
FY NaN
FY NaN
FY NaN
NaN - NaN
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '11
Dec 31, 2011
Dec '10
Dec 31, 2010
Dec '09
Dec 31, 2009
NaN - NaN
United States
997.73K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-43.14%
Log In
Log In
Log In
Log In
Upgrade